SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001070698-10-000096
Filing Date
2010-11-22
Accepted
2010-11-22 07:34:33
Documents
6
Period of Report
2010-08-31

Document Format Files

Seq Description Document Type Size
1 RAPTOR 10-K 083110 raptor10k083110.htm 10-K 2731252
2 EXHIBIT 21.1 LIST OF SUBSIDIARIES listofsubsdiaries.htm EX-21.1 7188
3 EXHIBIT 23.1 AUDITOR CONSENT auditorconsent2010.htm EX-23.1 5141
4 EXHBITI 31.1 CEO CERTIFICATION ceocertification2010.htm EX-31.1 9029
5 EXHIBIT 31.2 CFO CERTIFICATION cfocertification2010.htm EX-31.2 9190
6 EXHIBIT 32.1 CERTIFICATIONS certifications2010.htm EX-32.1 9236
  Complete submission text file 0001070698-10-000096.txt   2772950
Mailing Address 9 COMMERCIAL BLVD SUITE 200 NOVATO CA 94949
Business Address 9 COMMERCIAL BLVD SUITE 200 NOVATO CA 94949 415-382-1390
Raptor Pharmaceutical Corp (Filer) CIK: 0001070698 (see all company filings)

IRS No.: 860883978 | State of Incorp.: DE | Fiscal Year End: 0831
Type: 10-K | Act: 34 | File No.: 000-25571 | Film No.: 101207212
SIC: 2834 Pharmaceutical Preparations